Pharmacy

As health systems expand specialty pharmacy services, technology transitions are becoming unavoidable — and increasingly complex. Pharmacy leaders who have already navigated these shifts say success hinges less on the software itself and more on how organizations manage people, workflows…

Drugmakers plan to raise U.S. prices on at least 350 branded medications beginning Jan. 1, including treatments for cancer, COVID-19 and RSV, according to data provided exclusively to Reuters by healthcare research firm 3 Axis Advisors. The number of increases…

Saltville-based Southwest Virginia Community Health Systems plans to open a pharmacy within its Tazewell Community Health Center in early 2026. The Tazewell Community Health Center Pharmacy will serve both patients and the general public, according to a health system news…

Corcept Therapeutics has received a complete response letter from the FDA for its new drug application for relacorilant, a treatment for hypertension caused by hypercortisolism. In the Dec. 31 letter, the FDA acknowledged that Corcept’s GRACE trial met its primary…

Axsome Therapeutics received FDA acceptance and priority review designation for its supplemental new drug application for AXS-05, a treatment for agitation associated with Alzheimer’s disease. The FDA set a Prescription Drug User Fee Act action date of April 30, 2026.…

The following hospitals and health systems have recently posted job listings for pharmacy leaders. Note: This is not an exhaustive list. Listings were compiled from job-seeker websites.

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new pharmacologic treatment for motion sickness in more than four decades. Its efficacy is supported…

The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in September 2023 for discrepancies in the electronic listing file of…

Mark Cuban, co-founder of Cost Plus Drugs Co., and Optum CEO Patrick Conway, MD, sparred over drug prices, pharmacy benefit managers and a range of other healthcare issues during a Dec. 16 conversation in Washington, D.C. hosted by Johns Hopkins…

Specialty medications, which can cost between $10,000 and upward of $5 million, now account for 52% of U.S. pharmaceutical sales, according to a Dec. 30 report from the Healthcare Distribution Alliance, which represents pharmaceutical distributors.  These therapies pose significant logistics…